CD8A and nasopharyngeal carcinoma: Immunization with Epstein-Barr virus (EBV) peptide-pulsed dendritic cells induces functional CD8 + T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma